Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • le.nono
    Member
    • Sep 2012
    • 17

    PGM for mtDNA transcriptome

    Hi,

    Still new in the field but my lab is about to acquire a PGM or a Proton. our projects turn around the mitochondrie. I'd like to know if a PGM ihas enough capacity enough with the 318 chips for instance to perform sequencing such as whole transcriptome RNA-Seq (including mito transcripts and nuclar transcripts from the mito compartment) and a whole cell Chips-Seq analysis with a good coverage (30-40x)?

    Thank you.
    A
    Gene R' Us!
  • jonathanjacobs
    Member
    • Apr 2011
    • 23

    #2
    Probably not. You'll get about 5M reads on a good day with the Ion318 - which is good enough for polyA+ transcriptome sequencing; comparable to what you might expect from an Affymetrix array. We also do a lot of small RNA sequencing on the PGM - and it (316/318) seems to work quite well, but For total Transcriptome you are going to be better off with an Ion Proton or a MiSeq. You simply need more reads for that type of sample.
    @bioinformer
    http://www.linkedin.com/in/jonathanjacobs

    Comment

    • le.nono
      Member
      • Sep 2012
      • 17

      #3
      even with a rRNA depletion step ?
      Gene R' Us!

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
        by SEQadmin2


        Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

        The systematic characterization of the human proteome has
        ...
        Yesterday, 11:48 AM
      • SEQadmin2
        Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
        by SEQadmin2



        Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
        ...
        07-09-2026, 11:10 AM
      • SEQadmin2
        Cancer Drug Resistance: The Lingering Barrier to Rising Survival
        by SEQadmin2



        Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

        There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
        07-08-2026, 05:17 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, Yesterday, 11:10 AM
      0 responses
      8 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-13-2026, 10:26 AM
      0 responses
      30 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-09-2026, 10:04 AM
      0 responses
      39 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-08-2026, 10:08 AM
      0 responses
      25 views
      0 reactions
      Last Post SEQadmin2  
      Working...